Interferon-α Therapy in Sicilian and Sardinian Polytransfused Thalassaemic Patients with Chronic Hepatitis C

Pizzarelli G,Felicia Di Gregorio,Maria A. Romeo,Francesca Carboni,Domenico Pietro Paolo Gallisai,Antonello Solinas,Mariano Malaguarnera,Salvatore Musumeci

Interferon-α Therapy in Sicilian and Sardinian Polytransfused Thalassaemic Patients with Chronic Hepatitis C

1999

Pizzarelli G
Felicia Di Gregorio
Maria A. Romeo
Francesca Carboni
Domenico Pietro Paolo Gallisai
Antonello Solinas
Mariano Malaguarnera
Salvatore Musumeci

Objective: Our study was designed to evaluate the effects of 2 dosage schedules of recombinant interferon (IFN)-α (IFNα-2a and IFNα-2b) in reducing serum ALT and eradicating serum hepatitis C virus (HCV) RNA in β-thalassaemic patients with chronic hepatitis C.

Keywords:

Immunology
Hepatitis C virus
Chronic persistent hepatitis
Hepatitis C
RNA
Interferon
Virology
Recombinant DNA
Medicine
interferon α
Pharmacotherapy
chronic hepatitis
recombinant interferon
dosage schedule
Antibody
Molecular medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations